00:00 Introductions
02:10 The impact of plaque psoriasis
07:48 Absence of treatment or under treatment of plaque psoriasis
12:50 Prescribing novel systemic medications in plaque psoriasis as an advanced practice provider
15:46 Classifying moderate disease in plaque psoriasis
19:43 Getting payer approval for your patients with plaque psoriasis
23:18 Novel oral systemic treatments for plaque psoriasis
25:03 Pivotal clinical trial data on deucravacitinib
27:58 Deciding on aprimilast versus deucravacitinib for your patients with plaque psoriasis
31:53 Mechanism of action of deucravacitinib
38:13 Selecting a therapy in the evolving treatment landscape for your patient with plaque psoriasis
43:08 Educating your patients on injectables and orals systemic treatments
46:58 Summary
Read more:
A Patient-Centric Medcast on The Journey Through Moderate Plaque Psoriasis - MD Magazine